UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

Allosteric MAPKAPK2 inhibitors improve plaque stability in advanced atherosclerosis

PloS one, 2021-05, Vol.16 (5), p.e0246600

2021

Link zum Volltext

Verfügbarkeit prüfen

Identification of Hepatitis C Virus NS5A Inhibitors

Journal of Virology, 2010-01, Vol.84 (1), p.482-491

2010

Link zum Volltext

Verfügbarkeit prüfen

High-Throughput Melanin-Binding Affinity and In Silico Methods to Aid in the Prediction of Drug Exposure in Ocular Tissue

Journal of pharmaceutical sciences, 2015-12, Vol.104 (12), p.3997-4001

2015

Link zum Volltext

Verfügbarkeit prüfen

A Maltose-Binding Protein Fusion Construct Yields a Robust Crystallography Platform for MCL1

PloS one, 2015-04, Vol.10 (4), p.e0125010-e0125010

2015

Link zum Volltext

Verfügbarkeit prüfen

Large-scale chemical-genetics yields new M. tuberculosis inhibitor classes

Nature (London), 2019-07, Vol.571 (7763), p.72-78

2019

Link zum Volltext

Verfügbarkeit prüfen

Inhibitors of HCV NS5A: From Iminothiazolidinones to Symmetrical Stilbenes

ACS medicinal chemistry letters, 2011-03, Vol.2 (3), p.224-229

2011

Link zum Volltext

Verfügbarkeit prüfen

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

Nature (London), 2010-05, Vol.465 (7294), p.96-100

2010

Link zum Volltext

Verfügbarkeit prüfen

Discovery of Potent Hepatitis C Virus NS5A Inhibitors with Dimeric Structures

Antimicrobial Agents and Chemotherapy, 2011-08, Vol.55 (8), p.3795-3802

2011

Link zum Volltext

Verfügbarkeit prüfen

Chemical Screen for Vancomycin Antagonism Uncovers Probes of the Gram-Negative Outer Membrane

ACS chemical biology, 2021-05, Vol.16 (5), p.929-942

2021

Link zum Volltext

Verfügbarkeit prüfen

Single Diastereomer of a Macrolactam Core Binds Specifically to Myeloid Cell Leukemia 1 (MCL1)

ACS medicinal chemistry letters, 2014-12, Vol.5 (12), p.1308-1312

2014

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Obese Insulin-Resistant Mice With an Allosteric MAPKAPK2/3 Inhibitor Lowers Blood Glucose and Improves Insulin Sensitivity

Diabetes (New York, N.Y.), 2015-10, Vol.64 (10), p.3396-3405

2015

Link zum Volltext

Verfügbarkeit prüfen

Discovery of heterocyclic replacements for the coumarin core of anti-tubercular FadD32 inhibitors

Bioorganic & medicinal chemistry letters, 2018-12, Vol.28 (22), p.3529-3533

2018

Link zum Volltext

Verfügbarkeit prüfen

Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in Humans

Journal of medicinal chemistry, 2017-06, Vol.60 (11), p.4657-4664

2017

Link zum Volltext

Verfügbarkeit prüfen

Preclinical Development of Pentamidine Analogs Identifies a Potent and Nontoxic Antibiotic Adjuvant

ACS infectious diseases, 2022-04, Vol.8 (4), p.768-777

2022

Link zum Volltext

Verfügbarkeit prüfen

Discovery of diamide compounds as diacylglycerol acyltransferase 1 (DGAT1) inhibitors

Bioorganic & medicinal chemistry letters, 2016-02, Vol.26 (4), p.1245-1248

2016

Link zum Volltext

Verfügbarkeit prüfen

HCV NS5A replication complex inhibitors. Part 2: Investigation of stilbene prolinamides

Bioorganic & medicinal chemistry letters, 2012-10, Vol.22 (19), p.6063-6066

2012

Link zum Volltext

Verfügbarkeit prüfen

Intestinally Targeted Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitors Robustly Suppress Postprandial Triglycerides

ACS medicinal chemistry letters, 2012-05, Vol.3 (5), p.411-415

2012

Link zum Volltext

Verfügbarkeit prüfen

HCV NS5A Replication Complex Inhibitors. Part 4. Optimization for Genotype 1a Replicon Inhibitory Activity

Journal of medicinal chemistry, 2014-03, Vol.57 (5), p.1976-1994

2014

Link zum Volltext

Verfügbarkeit prüfen

Chemoselective Amination of 5-Bromo-2-chloro-3-fluoropyridine

Organic letters, 2007-05, Vol.9 (10), p.2039-2042

2007

Link zum Volltext

Verfügbarkeit prüfen

A new structural alert for benzimidazoles: 2,6-Dimethylphenyl substituents increase mutagenic potential and time-dependent CYP3A4 inhibition risk

Bioorganic & medicinal chemistry letters, 2011-03, Vol.21 (5), p.1422-1424

2011

Link zum Volltext

Verfügbarkeit prüfen

Antisense and small-molecule modulation of diacylglycerol acyltransferase

Expert opinion on therapeutic patents, 2007-11, Vol.17 (11), p.1331-1339

2007

Link zum Volltext

Verfügbarkeit prüfen

Oxime derivatives of sordaricin as potent antifungal agents

Bioorganic & medicinal chemistry letters, 2002-03, Vol.12 (6), p.943-946

2002

Link zum Volltext

Verfügbarkeit prüfen

Identification of a broad-Spectrum azasordarin with improved pharmacokinetic properties

Bioorganic & medicinal chemistry letters, 2003-04, Vol.13 (8), p.1419-1423

2003

Link zum Volltext

Verfügbarkeit prüfen

Sordarin Oxazepine Derivatives as Potent Antifungal Agents

Bioorganic & medicinal chemistry letters, 2002-10, Vol.12 (19), p.2757-2760

2002

Link zum Volltext

Verfügbarkeit prüfen

Mild deprotection of 2-(trimethylsilyl)ethyl esters

Tetrahedron letters, 2001-12, Vol.42 (49), p.8593-8595

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)
Japanisch
(3)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Allosteric MAPKAPK2 inhibitors improve plaque stability in advanced atherosclerosis

Identification of Hepatitis C Virus NS5A Inhibitors

High-Throughput Melanin-Binding Affinity and In Silico Methods to Aid in the Prediction of Drug Exposure in Ocular Tissue

A Maltose-Binding Protein Fusion Construct Yields a Robust Crystallography Platform for MCL1

Large-scale chemical-genetics yields new M. tuberculosis inhibitor classes

Inhibitors of HCV NS5A: From Iminothiazolidinones to Symmetrical Stilbenes

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

Discovery of Potent Hepatitis C Virus NS5A Inhibitors with Dimeric Structures

Chemical Screen for Vancomycin Antagonism Uncovers Probes of the Gram-Negative Outer Membrane

Single Diastereomer of a Macrolactam Core Binds Specifically to Myeloid Cell Leukemia 1 (MCL1)

Treatment of Obese Insulin-Resistant Mice With an Allosteric MAPKAPK2/3 Inhibitor Lowers Blood Glucose and Improves Insulin Sensitivity

Discovery of heterocyclic replacements for the coumarin core of anti-tubercular FadD32 inhibitors

Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in Humans

Preclinical Development of Pentamidine Analogs Identifies a Potent and Nontoxic Antibiotic Adjuvant

Discovery of diamide compounds as diacylglycerol acyltransferase 1 (DGAT1) inhibitors

HCV NS5A replication complex inhibitors. Part 2: Investigation of stilbene prolinamides

Intestinally Targeted Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitors Robustly Suppress Postprandial Triglycerides

HCV NS5A Replication Complex Inhibitors. Part 4. Optimization for Genotype 1a Replicon Inhibitory Activity

Chemoselective Amination of 5-Bromo-2-chloro-3-fluoropyridine

A new structural alert for benzimidazoles: 2,6-Dimethylphenyl substituents increase mutagenic potential and time-dependent CYP3A4 inhibition risk

Antisense and small-molecule modulation of diacylglycerol acyltransferase

Oxime derivatives of sordaricin as potent antifungal agents

Identification of a broad-Spectrum azasordarin with improved pharmacokinetic properties

Sordarin Oxazepine Derivatives as Potent Antifungal Agents

Mild deprotection of 2-(trimethylsilyl)ethyl esters

Suchergebnisse filtern